# Correction: Identification and validation of targets of swertiamarin on idiopathic pulmonary fibrosis through bioinformatics and molecular docking-based approach

**Authors:** Jun Chang, Shaoqing Zou, Yiwen Xiao, Du Zhu

PMC · DOI: 10.1186/s12906-024-04616-w · BMC Complementary Medicine and Therapies · 2024-08-21

## Full-text entities

- **Diseases:** idiopathic pulmonary fibrosis (MESH:D054990)
- **Chemicals:** swertiamarin (MESH:C013270)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11340049/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC11340049/full.md

---
Source: https://tomesphere.com/paper/PMC11340049